The psychotropically active compounds of the Mexican hallucinogenic fungus Psilocybe mexicana were isolated and crystallized. Two new substances, named psilocybin and psilocin, are present in the fruit bodies, artificially cultivated mycelium, and sclerotia. The dried mushroom contains 0.2 to 0.4 percent psilocybin; psilocin is present at most in trace amounts only.
Psilocybin, a hallucinogen found in certain mushrooms, has shown promise in treating anxiety and depression. In a study with 100 participants, 60% reported significant reductions in anxiety symptoms after a single dose. The chemical synthesis of psilocybin mimics natural alkaloids, enhancing its therapeutic potential. Participants experienced a profound shift in perspective, with 75% noting improved emotional well-being. These findings highlight the efficacy of psychedelics like psilocybin in mental health treatment, suggesting a transformative approach to therapy.